Immune cell responses and mucosal barrier disruptions in chronic rhinosinusitis

Immune Network

Volumn 17, Issue 1, 2017, Pages 60-67

  Khalmuratova, Roza ^a   Park, Jong Wan ^a   Shin, Hyun Woo ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Chronic rhinosinusitis; Cytokines; Eosinophils; Epithelial mesenchymal transition; Nasal mucosa; Nasal polyps

Indexed keywords

CYTOKINE;

ASIAN; CHRONIC RHINOSINUSITIS; DISEASE CLASSIFICATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HYPOXIA; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; NONHUMAN; NOSE EPITHELIUM; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVIEW;

EID: 85020062898     PISSN: 15982629     EISSN: 20926685     Source Type: Journal    
DOI: 10.4110/in.2017.17.1.60     Document Type: Review

References (65)

1. Hamilos, D. L. 2011. Chronic rhinosinusitis: epidemiology and medical management. J. Allergy Clin. Immunol. 128: 693-707.
2. Soler, Z. M., J. C. Mace, J. R. Litvack, and T. L. Smith. 2012. Chronic rhinosinusitis, race, and ethnicity. Am. J. Rhinol. Allergy 26: 110-116.
3. Stevens, W. W., R. J. Lee, R. P. Schleimer, and N. A. Cohen. 2015. Chronic rhinosinusitis pathogenesis. J. Allergy Clin. Immunol. 136: 1442-1453.
4. Kern, R. C., D. B. Conley, W. Walsh, R. Chandra, A. Kato, A. Tripathi-Peters, L. C. Grammer, and R. P. Schleimer. 2008. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Am. J. Rhinol. 22: 549-559.
5. Payne, S. C., L. Borish, and J. W. Steinke. 2011. Genetics and phenotyping in chronic sinusitis. J. Allergy Clin. Immunol. 128: 710-720.
6. Cao, P. P., H. B. Li, B. F. Wang, S. B. Wang, X. J. You, Y. H. Cui, D. Y. Wang, M. Desrosiers, and Z. Liu. 2009. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J. Allergy Clin. Immunol. 124:478-84, 484.
7. Kim, J. W., S. L. Hong, Y. K. Kim, C. H. Lee, Y. G. Min, and C. S. Rhee. 2007. Histological and immunological features of non-eosinophilic nasal polyps. Otolaryngol. Head Neck Surg. 137: 925-930.
8. Ikeda, K., A. Shiozawa, N. Ono, T. Kusunoki, M. Hirotsu, H. Homma, T. Saitoh, and J. Murata. 2013. Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil. Laryngoscope 123: E1-E9.
9. Wen, W., W. Liu, L. Zhang, J. Bai, Y. Fan, W. Xia, Q. Luo, J. Zheng, H. Wang, Z. Li, J. Xia, H. Jiang, Z. Liu, J. Shi, H. Li, G. Xu; Nasal Health Group, China (NHGC). 2012. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J. Allergy Clin. Immunol. 129: 1522-1528.
10. Kim, S. J., K. H. Lee, S. W. Kim, J. S. Cho, Y. K. Park, and S. Y. Shin. 2013. Changes in histological features of nasal polyps in a Korean population over a 17-year period. Otolaryngol. Head Neck Surg. 149: 431-437.
11. Van, Z. T., S. Claeys, P. Gevaert, M. G. Van, G. Holtappels, C. P. Van, and C. Bachert. 2006. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61: 1280-1289.
12. Van, B. N., C. A. Perez-Novo, T. M. Basinski, Z. T. Van, G. Holtappels, R. N. De, C. Schmidt-Weber, C. Akdis, C. P. Van, C. Bachert, and P. Gevaert. 2008. T-cell regulation in chronic paranasal sinus disease. J. Allergy Clin. Immunol. 121: 1435-1441.
13. Park, S. J., T. H. Kim, Y. J. Jun, S. H. Lee, H. Y. Ryu, K. J. Jung, J. Y. Jung, G. H. Hwang, and S. H. Lee. 2013. Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3. J. Allergy Clin. Immunol. 131: 772-780.
14. Nagarkar, D. R., J. A. Poposki, B. K. Tan, M. R. Comeau, A. T. Peters, K. E. Hulse, L. A. Suh, J. Norton, K. E. Harris, L. C. Grammer, R. K. Chandra, D. B. Conley, R. C. Kern, R. P. Schleimer, and A. Kato. 2013. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J. Allergy Clin. Immunol. 132: 593-600.
15. Zhang, N., Z. T. Van, C. Perez-Novo, B. N. Van, G. Holtappels, N. DeRuyck, C. P. Van, and C. Bachert. 2008. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J. Allergy Clin. Immunol. 122: 961-968.
16. Van, B. N., L. Derycke, C. A. Perez-Novo, P. Gevaert, G. Holtappels, R. N. De, C. Cuvelier, C. P. Van, and C. Bachert. 2009. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J. Allergy Clin. Immunol. 124: 253-259.
17. Sejima, T., G. Holtappels, H. Kikuchi, S. Imayoshi, K. Ichimura, and C. Bachert. 2012. Cytokine profiles in Japanese patients with chronic rhinosinusitis. Allergol. Int. 61: 115-122.
18. Shi, L. L., P. Xiong, L. Zhang, P. P. Cao, B. Liao, X. Lu, Y. H. Cui, and Z. Liu. 2013. Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns. Allergy 68: 101-109.
19. Van, B. N., C. PN, C. K. Van, R. N. De, G. Holtappels, C. P. Van, P. Gevaert, and C. Bachert. 2012. Inflammation and remodelling patterns in early stage chronic rhinosinusitis. Clin. Exp. Allergy 42: 883-890.
20. Bachert, C., B. N. Van, E. Toskala, N. Zhang, H. Olze, G. Scadding, C. M. Van Drunen, J. Mullol, L. Cardell, P. Gevaert, Z. T. Van, S. Claeys, C. Hallden, K. Kostamo, U. Foerster, M. Kowalski, K. Bieniek, A. Olszewska-Ziaber, E. Nizankowska-Mogilnicka, A. Szczeklik, M. Swierczynska, M. Arcimowicz, V. Lund, W. Fokkens, T. Zuberbier, C. Akdis, G. Canonica, C. P. Van, P. Burney, and J. Bousquet. 2009. Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study. Allergy 64: 520-533.
21. Polzehl, D., P. Moeller, H. Riechelmann, and S. Perner. 2006. Distinct features of chronic rhinosinusitis with and without nasal polyps. Allergy 61: 1275-1279.
22. Kato, A. 2015. Immunopathology of chronic rhinosinusitis. Allergol. Int. 64: 121-130.
23. Katotomichelakis, M., P. Tantilipikorn, G. Holtappels, R. N. De, L. Feng, Z. T. Van, S. Muangsomboon, P. Jareonchasri, C. Bunnag, V. Danielides, C. A. Cuvelier, P. W. Hellings, C. Bachert, and N. Zhang. 2013. Inflammatory patterns in upper airway disease in the same geographical area may change over time. Am. J. Rhinol. Allergy 27: 354-360.
24. Park, Y. M., and B. S. Bochner. 2010. Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol. Res. 2: 87-101.
25. Kouro, T., and K. Takatsu. 2009. IL-5- and eosinophilmediated inflammation: from discovery to therapy. Int. Immunol. 21: 1303-1309.
26. Bachert, C., M. Wagenmann, U. Hauser, and C. Rudack. 1997. IL-5 synthesis is upregulated in human nasal polyp tissue. J. Allergy Clin. Immunol. 99: 837-842.
27. Mackay, C. R. 2001. Chemokines: immunology’s high impact factors. Nat. Immunol. 2: 95-101.
28. Yao, T., Y. Kojima, A. Koyanagi, H. Yokoi, T. Saito, K. Kawano, M. Furukawa, T. Kusunoki, and K. Ikeda. 2009. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients. Laryngoscope 119: 1053-1059.
29. Olze, H., U. Forster, T. Zuberbier, L. Morawietz, and E. O. Luger. 2006. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. Rhinology 44: 145-150.
30. Early, S. B., K. Hise, J. K. Han, L. Borish, and J. W. Steinke. 2007. Hypoxia stimulates inflammatory and fibrotic responses from nasal-polyp derived fibroblasts. Laryngoscope 117: 511-515.
31. Nissim Ben Efraim, A. H., R. Eliashar, and F. Levi-Schaffer. 2010. Hypoxia modulates human eosinophil function. Clin. Mol. Allergy 8: 10.
32. Takabayashi, T., A. Kato, A. T. Peters, L. A. Suh, R. Carter, J. Norton, L. C. Grammer, B. K. Tan, R. K. Chandra, D. B. Conley, R. C. Kern, S. Fujieda, and R. P. Schleimer. 2012. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. 130: 410-420.
33. Cao, P. P., Y.N. Zhang, B. Liao, J. Ma, B. F. Wang, H. Wang, M. Zeng, W. H. Liu, R. P. Schleimer, and Z. Liu. 2014. Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non-eosinophilic, chronic rhinosinusitis with nasal polyps. Clin. Exp. Allergy 44: 690-700.
34. Mahdavinia, M., R. G. Carter, C. J. Ocampo, W. Stevens, A. Kato, B. K. Tan, R. C. Kern, D. B. Conley, R. Chandra, K. E. Hulse, L. A. Suh, J. E. Norton, A. T. Peters, L. C. Grammer, III, L. B. Schwartz, and R. P. Schleimer. 2014. Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity. J. Allergy Clin. Immunol. 133: 1759-1763.
35. Soyka, M. B., P. Wawrzyniak, T. Eiwegger, D. Holzmann, A. Treis, K. Wanke, J. I. Kast, and C. A. Akdis. 2012. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4. J. Allergy Clin. Immunol. 130: 1087-1096.
36. Nomura, K., K. Obata, T. Keira, R. Miyata, S. Hirakawa, K. Takano, T. Kohno, N. Sawada, T. Himi, and T. Kojima. 2014. Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells. Respir. Res. 15: 21.
37. Shin, H. W., K. Cho, D. W. Kim, D. H. Han, R. Khalmuratova, S. W. Kim, S. Y. Jeon, Y. G. Min, C. H. Lee, C. S. Rhee, and J. W. Park. 2012. Hypoxia-inducible factor 1 mediates nasal polypogenesis by inducing epithelial-to-mesenchymal transition. Am. J. Respir. Crit Care Med. 185: 944-954.
38. Hupin, C., S. Gohy, C. Bouzin, M. Lecocq, M. Polette, and C. Pilette. 2014. Features of mesenchymal transition in the airway epithelium from chronic rhinosinusitis. Allergy 69: 1540-1549.
39. Lee, M., D. W. Kim, H. Yoon, D. So, R. Khalmuratova, C. S. Rhee, J. W. Park, and H. W. Shin. 2016. Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transition. J. Allergy Clin. Immunol. 137: 87-98.
40. Lim, J. H., Y. M. Lee, Y. S. Chun, J. Chen, J. E. Kim, and J. W. Park. 2010. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell 38: 864-878.
41. Yoon, H., S. H. Shin, D. H. Shin, Y. S. Chun, and J. W. Park. 2014. Differential roles of Sirt1 in HIF-1alpha and HIF-2alpha mediated hypoxic responses. Biochem. Biophys. Res. Commun. 444: 36-43.
42. Kim, S. W., D. W. Kim, R. Khalmuratova, J. H. Kim, M. H. Jung, D. Y. Chang, E. C. Shin, H. K. Lee, H. W. Shin, C. S. Rhee, S. Y. Jeon, and Y. G. Min. 2013. Resveratrol prevents development of eosinophilic rhinosinusitis with nasal polyps in a mouse model. Allergy 68: 862-869.
43. Zhang, N., C. K. Van, E. Gevaert, and C. Bachert. 2016. Barrier function of the nasal mucosa in health and type-2 biased airway diseases. Allergy 71: 295-307.
44. Esplugues, E., S. Huber, N. Gagliani, A. E. Hauser, T. Town, Y. Y. Wan, W. O’Connor, Jr., A. Rongvaux, R. N. Van, A. M. Haberman, Y. Iwakura, V. K. Kuchroo, J. K. Kolls, J. A. Bluestone, K. C. Herold, and R. A. Flavell. 2011. Control of TH17 cells occurs in the small intestine. Nature 475: 514-518.
45. Ke, Y., K. Liu, G. Q. Huang, Y. Cui, H. J. Kaplan, H. Shao, and D. Sun. 2009. Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. J. Immunol. 182: 3183-3190.
46. Otani, K., T. Watanabe, T. Tanigawa, H. Okazaki, H. Yamagami, K. Watanabe, K. Tominaga, Y. Fujiwara, N. Oshitani, and T. Arakawa. 2009. Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis. Biochem. Biophys. Res. Commun. 382: 252-258.
47. Pappu, R., V. Ramirez-Carrozzi, and A. Sambandam. 2011. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 134: 8-16.
48. Zizzo, G., and P. L. Cohen. 2013. IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. J. Immunol. 190: 5237-5246.
49. Lee, M., D.W. Kim, and H. W. Shin. 2017. Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps. Curr. Opin. Allergy Clin. Immunol. 17: 17-22.
50. Pappu, R., S. Rutz, and W. Ouyang. 2012. Regulation of epithelial immunity by IL-17 family cytokines. Trends Immunol. 33: 343-349.
51. Hurst, S. D., T. Muchamuel, D. M. Gorman, J. M. Gilbert, T. Clifford, S. Kwan, S. Menon, B. Seymour, C. Jackson, T. T. Kung, J. K. Brieland, S. M. Zurawski, R. W. Chapman, G. Zurawski, and R. L. Coffman. 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169: 443-453.
52. Fort, M. M., J. Cheung, D. Yen, J. Li, S. M. Zurawski, S. Lo, S. Menon, T. Clifford, B. Hunte, R. Lesley, T. Muchamuel, S. D. Hurst, G. Zurawski, M. W. Leach, D. M. Gorman, and D. M. Rennick. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2- associated pathologies in vivo. Immunity 15: 985-995.
53. Ballantyne, S. J., J. L. Barlow, H. E. Jolin, P. Nath, A. S. Williams, K. F. Chung, G. Sturton, S. H. Wong, and A. N. McKenzie. 2007. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J. Allergy Clin. Immunol. 120: 1324-1331.
54. Shin, H. W., D. K. Kim, M. H. Park, K. M. Eun, M. Lee, D. So, I. G. Kong, J. H. Mo, M. S. Yang, H. R. Jin, J. W. Park, and D. W. Kim. 2015. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. J. Allergy Clin. Immunol. 135: 1476-1485.
55. Miljkovic, D., A. Bassiouni, C. Cooksley, J. Ou, E. Hauben, P. J. Wormald, and S. Vreugde. 2014. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. Allergy 69: 1154-1161.
56. Mjosberg, J. M., S. Trifari, N. K. Crellin, C. P. Peters, C. M. van Drunen, B. Piet, W. J. Fokkens, T. Cupedo, and H. Spits. 2011. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12: 1055-1062.
57. Smith, D. E. 2010. IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin. Exp. Allergy 40: 200-208.
58. Bulek, K., S. Swaidani, M. Aronica, and X. Li. 2010. Epithelium: the interplay between innate and Th2 immunity. Immunol. Cell Biol. 88: 257-268.
59. Lam, M., L. Hull, R. McLachlan, K. Snidvongs, D. Chin, E. Pratt, L. Kalish, R. Sacks, P. Earls, W. Sewell, and R. J. Harvey. 2013. Clinical severity and epithelial endotypes in chronic rhinosinusitis. Int. Forum Allergy Rhinol. 3: 121-128.
60. Kim, D. K., H. R. Jin, K. M. Eun, J. H. Mo, S. H. Cho, S. Oh, D. Cho, and D. W. Kim. 2016. The role of interleukin-33 in chronic rhinosinusitis. Thorax doi: 10.1136/ thoraxjnl-2016-208772.
61. Allakhverdi, Z., M. R. Comeau, D. E. Smith, D. Toy, L. M. Endam, M. Desrosiers, Y. J. Liu, K. J. Howie, J. A. Denburg, G. M. Gauvreau, and G. Delespesse. 2009. CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J. Allergy Clin. Immunol. 123: 472-478.
62. Kim, D. W., K. M. Eun, H. R. Jin, S. H. Cho, and D. K. Kim. 2016. Prolonged allergen exposure is associated with increased thymic stromal lymphopoietin expression and Th2-skewing in mouse models of chronic rhinosinusitis. Laryngoscope 126:E265-E272.
63. Kim, D. W., R. Khalmuratova, D. G. Hur, S. Y. Jeon, S. W. Kim, H. W. Shin, C. H. Lee, and C. S. Rhee. 2011. Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model. Am. J. Rhinol. Allergy 25: e255-e261.
64. Khalmuratova, R., M. Lee, D. W. Kim, J. W. Park, and H. W. Shin. 2016. Induction of nasal polyps using house dust mite and Staphylococcal enterotoxin B in C57BL/6 mice. Allergol. Immunopathol. (Madr.) 44: 66-75.
65. Shin H.W. 2016. Animal models in CRS and pathophysiologic insights gained: A systematic review. Laryngoscope Investig. Otolaryngol. 1: 116-123.